Simponi 100 MG/ML pen injectorml
Ended Awarded Last action
- Contract number
- SPE2DR26F9DZD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,667
Award facts
- Contract value 100% obligated
- $14,667.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,667.19 to AmerisourceBergen Drug Corp for the supply of Simponi 100 mg/mL pen injector on January 29, 2026, with an ultimate completion date of January 30, 2026. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this procurement, with performance also occurring at its Conshohocken facility. The parent organization, Cencora, Inc. (doing business as AmerisourceBergen), holds a $999.99 billion IDC with DLA Troop Support Medical extending through December 2026, which serves as the comprehensive vehicle enabling delivery of pharmaceutical products and medical supplies to support military healthcare programs globally.
This award exemplifies the critical role AmerisourceBergen plays within the federal pharmaceutical supply chain, particularly in delivering specialty medications to military treatment facilities and veterans' healthcare systems. Simponi, a biologic immunosuppressive medication used to treat autoimmune conditions, represents the type of specialized pharmaceutical commodity routinely procured through the DLA Troop Support Medical contract vehicle. The delivery order structure allows for flexible, on-demand fulfillment of medical supply requirements while maintaining firm pricing, demonstrating the efficiency of the IDC model in meeting government healthcare needs across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9DZD?
SPE2DR26F9DZD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F9DZD worth?
The government has obligated $14,667 on SPE2DR26F9DZD.
Is contract SPE2DR26F9DZD an order under another contract?
Yes. SPE2DR26F9DZD is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DZD competed?
The extent of competition for SPE2DR26F9DZD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award